China Pharmaceutical Manufacturing: Navigating the Landscape

Market Overview

China has rapidly emerged as a major pharmaceutical manufacturing destination with growing capabilities.

Strengths

Scale and Capacity

• Large manufacturing base
• Significant recent investment
• Growing biologics capability

Cost Competitiveness

• Competitive pricing
• Efficient operations
• Government support

Regulatory Environment

NMPA Standards

• Increasing alignment with ICH
• Growing inspection rigor
• Data integrity focus

International Recognition

• WHO prequalification growth
• FDA approvals increasing
• EU GMP certifications

Working with Chinese CDMOs

Due Diligence Essentials

• On-site audits critical
• Quality system assessment
• Regulatory history review

Cultural Considerations

• Relationship importance
• Communication styles
• Local partnerships helpful

Risk Considerations

• IP protection concerns
• Supply chain dependencies
• Geopolitical factors